CME Group Inc. achieved a record-breaking fourth quarter and full year in 2025, with total revenues reaching $1.6 billion for Q4 and $6.5 billion for the full year. The company reported strong growth across key financial metrics, including a 6% increase in annual revenue and a 13% increase in annual market data revenue, driven by record average daily volume.

CME Group delivered robust Q3 results, with $1.5B in revenue and $908M in net income, supported by strong derivatives trading and record market data revenue.

CME Group delivered all-time high financial results in Q2 2025, driven by record trading volumes and strong demand for benchmark futures and options.

CME Group delivered its strongest quarter ever with record financial results across key metrics, driven by increased trading volumes across all asset classes and a surge in demand amid economic uncertainty.

CME Group Inc. reported strong financial results for Q4 2024, with a 6% increase in revenue, adjusted net income, and adjusted earnings per share. Revenue reached $1.5 billion, operating income was $947 million, and net income stood at $875 million. Adjusted net income was $919 million, with adjusted diluted EPS of $2.52. The company also saw an increase in clearing and transaction fees revenue and a strong performance across asset classes.

CME Group reported a record-breaking Q3 2024, achieving all-time high revenue of $1.6 billion and an operating income of $1.0 billion. Net income reached $913 million, with diluted earnings per share at $2.50. Adjusted net income was $977 million, and adjusted diluted earnings per share were $2.68.

CME Group reported record revenue of $1.5 billion for Q2 2024, with operating income of $1.0 billion. Net income was $883 million, and diluted earnings per share were $2.42. Adjusted net income reached $932 million, with adjusted diluted earnings per share at $2.56. The company experienced year-over-year growth across all asset classes, with average daily volume (ADV) up 16% in commodities and 13% in financial markets.

CME Group reported a strong first quarter in 2024, with revenue reaching $1.5 billion and operating income at $960 million. Net income stood at $855 million, with diluted earnings per share at $2.35. On an adjusted basis, net income was $911 million, and diluted earnings per share was $2.50.

CME Group reported a successful fourth quarter and full year of 2023, marked by record revenue and adjusted earnings. The company's Q4 performance was bolstered by a significant increase in interest rate volumes, particularly Treasury futures ADV. Average daily volume reached 25.5 million contracts in Q4, up 17% compared to the same period in 2022.

CME Group reported a revenue of $1.3 billion and an operating income of $820 million for Q3 2023. Net income stood at $750 million, with diluted earnings per share at $2.06. On an adjusted basis, net income was $818 million, and diluted earnings per share reached $2.25.

CME Group reported a 10% increase in revenue and a 17% rise in adjusted earnings per share in Q2 2023, driven by ongoing uncertainty in macroeconomic and geopolitical environments.

CME Group's Q1 2023 saw the highest quarterly adjusted net income and adjusted earnings per share ever, with revenue reaching $1.4 billion and operating income at $914 million. The company experienced a surge in trading volume, with total daily volume surpassing 25 million contracts 28 times during the quarter, including a new single-day volume record of 66.3 million contracts on March 13.

CME Group reported Q4 2022 financial results with a revenue of $1.2 billion and an operating income of $668 million. Net income was $638 million, with diluted earnings per share at $1.75. Adjusted net income reached $698 million, and adjusted diluted earnings per share were $1.92. The company achieved a record average daily volume of 21.8 million contracts during the quarter.

CME Group reported a strong Q3 2022 with a 26% increase in trading volume leading to double-digit revenue growth. The company's average daily volume was 22.4 million contracts. Revenue reached $1.2 billion, operating income was $739 million, and net income was $680 million, with diluted earnings per share at $1.87 ($1.98 on an adjusted basis).

CME Group's Q2 2022 financial results showed a revenue of $1.2 billion and an operating income of $750 million. Net income was reported at $663 million, with diluted earnings per share at $1.82. Adjusted net income reached $717 million, and adjusted diluted earnings per share was $1.97.

CME Group reported a strong first quarter in 2022, with revenue of $1.3 billion and operating income of $859 million. Net income reached $711 million, with diluted earnings per share at $1.95. Adjusted net income was $766 million, and adjusted diluted earnings per share were $2.11.

CME Group reported Q4 2021 revenue of $1.1 billion and operating income of $632 million. Net income was $625 million, with diluted earnings per share at $1.71. Average daily volume was 20.5 million contracts, up 26% versus Q4 2020.

CME Group's Q3 2021 results showed robust volume growth as clients managed risks amid economic uncertainty. Average daily volume grew 14% year over year, driven by interest rates, energy, and options products. The company also focused on product innovation and strategic execution, including the OSTTRA joint venture.

CME Group reported a revenue of $1.2 billion and an operating income of $675 million for Q2 2021. The average daily volume grew by 5%, driven by increases in Interest Rates, Agricultural, and Options markets. The company also introduced innovative new products, including micro-sized contracts and ESG-focused futures contracts.

CME Group reported a strong first quarter in 2021 with increased demand for products due to potential post-pandemic economic recovery. The company's revenue was $1.3 billion, and operating income was $725 million. Net income was $574 million, with diluted earnings per share at $1.60.

CME Group reported Q4 2020 revenue of $1.1 billion and operating income of $515 million. Net income was $424 million, with diluted earnings per share at $1.18. Adjusted net income was $497 million, and adjusted diluted earnings per share were $1.39.

CME Group reported a revenue of $1.1 billion and an operating income of $525 million for Q3 2020. The net income was $412 million, with a diluted earnings per share of $1.15. On an adjusted basis, the net income was $495 million and diluted earnings per share was $1.38.

CME Group reported Q2 2020 financial results with revenue of $1.2 billion and operating income of $638 million. Net income was $503 million, with diluted earnings per share at $1.40. Adjusted net income reached $583 million, and adjusted diluted earnings per share were $1.63.

CME Group's Q1 2020 financial results showed a revenue of $1.5 billion and an operating income of $960 million. The net income was $766 million, with a diluted earnings per share of $2.14. On an adjusted basis, the net income was $836 million and diluted earnings per share were $2.33.

CME Group's Q4 2019 results showed a revenue of $1.1 billion and an operating income of $573 million. Net income was $469 million, with diluted earnings per share at $1.31. Adjusted net income reached $544 million, with diluted earnings per share at $1.52. The average daily volume was 16.9 million contracts, a 19% decrease compared to Q4 2018.